Psyence Biomed Announces Initiation of First Trial Site in Australia for Its Phase Iib Study of Nature Derived Psilocybin as a Potential Treatment for Adjustment Disorder in Palliative Care
Psyence Biomed宣佈在澳洲啓動了其第一家臨床試驗中心，進行其自然源賦性芬古尼治療臨終關懷調適障礙的II期研究。
